解放军总医院陆菊明口服降糖.pptVIP

* 汇总近期四项大型临床研究的结果，UKPDS与其他强化治疗研究相比，入选患者为新诊断患者，病程最短，而平均治疗的时间最长，由此我们得到一个启示，早期治疗、长期控制是降低大血管并发症的关键。 * Purpose: To provide a high-level overview of the key mechanisms and target sites for the currently available antihyperglycemic classes. Takeaway: Different drug classes with different and complementary mechanisms may be suitable for combination therapy to address multiple pathophysiologies and maximize A1C control. Speaker notes The various therapeutic agents currently available for the treatment of type 2 diabetes act on different pathways to control hyperglycemi.1,2 [Slide build for each